Picodya to play key role in Israel’s war on coronavirus
Picodya Technologies Ltd. receives approval for a third program from the Israeli Innovation Authority, including a substantial grant offered as part of a large-scale initiative to promote the development of breakthrough technologies that will help to combat the current coronavirus pandemic and advance public health in Israel. Picodya will adapt its innovative B-Matrix™ platform to conduct point-of-care serological testing for a panel of respiratory diseases, including COVID-19.
>> www.innovationisrael.org.il
